aex-2 Antibody

Shipped with Ice Packs
In Stock

Description

Analysis of "aex-2 Antibody": Possible Confusions or Typographical Errors

The term "aex-2" does not match any antibody designation, clinical trial identifier, or biochemical entity in the provided materials. Potential misinterpretations include:

  • AEX (Anion-Exchange Chromatography): A method used in antibody purification (e.g., for monoclonal antibodies like IgG4 ), but not directly linked to antibody nomenclature.

  • ACE2 Antibodies: Autoantibodies against angiotensin-converting enzyme 2 (ACE2) are discussed in SARS-CoV-2 research (e.g., ), but these are unrelated to "aex-2."

  • Experimental Antibody Designations: No clinical trials or preclinical studies in the sources reference "aex-2" (e.g., ARX517, ARX788 in , or broadly neutralizing antibodies in ).

Related Antibody Research Contexts

While "aex-2 Antibody" is not documented, the following antibody-related topics are well-represented in the sources:

Anion-Exchange Chromatography (AEX) in Antibody Characterization

AEX is a critical analytical technique for charge variant analysis of antibodies, particularly IgG4 subclasses ( ):

ParameterIgG1 AntibodiesIgG4 Antibodies
pI (Isoelectric Point)High (>7.5)Lower (acidic)
AEX-MS UtilityLimited due to basic pIHigh resolution for charge variants (e.g., Fc deamidation)
ApplicationsLess commonCharge heterogeneity profiling, multiple attribute monitoring (MAM)

Key Findings:

  • AEX-MS enables site-specific separation of IgG4 Fc deamidation variants ( ).

  • PNGase F/IdeS digestion improves chromatographic resolution for IgG4 mAbs ( ).

ACE2 Autoantibodies in SARS-CoV-2 Infection

ACE2 autoantibodies are observed in COVID-19 patients, with potential implications for long-term sequelae:

StudyPrevalenceAssociation with Disease Severity
(Inpatient+ Group)93% (IgG)Correlated with RBD antibody presence
(Cohort of 1,139)1.5% (IgG)Higher titers in severe cases

Mechanisms:

  • ACE2 antibodies may arise as anti-idiotypic responses to anti-RBD antibodies ( ).

  • Rare in outpatient/mild cases, suggesting severity-dependent induction ( ).

Broadly Neutralizing Antibodies Against SARS-CoV-2

Monoclonal antibodies (e.g., sotrovimab, REGN10933) neutralize viral variants through epitope-specific binding ( ):

AntibodyTarget EpitopeNeutralization Efficacy (IC50)
COV2-2130RBDEffective against Omicron (B.1.1.529)
ADI-58125S2 subunitCross-reactive with SARS-CoV-1

Recommendations for Further Inquiry

  1. Verify Nomenclature: Confirm if "aex-2" refers to a proprietary compound, experimental code, or typographical error (e.g., "ACE2" or "AEX").

  2. Explore AEX Applications: For antibody characterization, focus on AEX-MS methodologies for IgG4 variants ( ).

  3. ACE2 Autoantibodies: Investigate their role in COVID-19 pathophysiology and long-term outcomes ( ).

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
aex-2 antibody; T14B1.2G-protein coupled receptor aex-2 antibody; Aboc antibody; expulsion defective protein 2 antibody
Target Names
aex-2
Uniprot No.

Target Background

Function
The aex-2 antibody targets the G-protein coupled receptor for the nlp-40 neuropeptide. This receptor's activity is mediated by G proteins, which in turn activate adenylyl cyclase. The aex-2 receptor plays a crucial role in the defecation motor program, a coordinated series of three muscle contractions occurring every 45 seconds. Specifically, it functions in GABAergic neurons, such as AVL and DVB, to control the expulsion step of defecation. Furthermore, it is essential for fatty acid uptake and metabolism by intestinal cells, thereby regulating triglyceride levels in the intestine.
Database Links

KEGG: cel:CELE_T14B1.2

STRING: 6239.T14B1.2

UniGene: Cel.19809

Protein Families
G-protein coupled receptor 1 family
Subcellular Location
Cell membrane; Multi-pass membrane protein. Cell projection, cilium.
Tissue Specificity
Expressed in the intestinal muscle, anal depressor, AVL and DVB GABAergic neurons, enteric muscles, the nerve ring, the ventral nerve cord and head mesodermal cells.

Q&A

What is the aex-2 protein in C. elegans and what biological functions does it serve?

The aex-2 gene in C. elegans encodes a G protein-coupled receptor that plays a critical role in the nematode's defecation motor program and neuronal signaling pathways. It functions in the enteric muscle contraction phase of defecation and is expressed in GABAergic neurons that innervate enteric muscles. The protein is essential for proper neural circuit function and intestinal rhythm regulation in these nematodes .

In experimental evolution studies with C. elegans, aex-2 has been used as a marker for studying phenotypic plasticity and adaptation to variable environments. Understanding its function provides insights into fundamental aspects of neuromuscular coordination in invertebrate systems .

What are the specifications of commercially available aex-2 antibodies?

The commercially available aex-2 antibody has the following specifications:

  • Type: Polyclonal antibody

  • Host: Rabbit

  • Immunogen: Recombinant Caenorhabditis elegans aex-2 protein

  • Isotype: IgG

  • Validated applications: ELISA and Western Blot (WB)

  • Species reactivity: Invertebrates

  • Purification method: Antigen affinity purified

  • UniProt number: G5ECD9

What components are typically included in an aex-2 antibody research kit?

The standard research kit for aex-2 antibody typically includes:

  • 2mg of rabbit polyclonal antibodies purified by antigen affinity

  • 200μg of antigens (used as positive control)

  • 1ml pre-immune serum (used as negative control)

This comprehensive package allows researchers to conduct proper controlled experiments with appropriate validation of antibody specificity in their experimental systems.

What are the recommended storage conditions for maintaining aex-2 antibody activity?

For optimal stability and functionality, aex-2 antibodies should be stored at either -20°C or -80°C . To minimize freeze-thaw cycles that can degrade antibody quality, it is recommended to aliquot the antibody solution upon receipt. Each aliquot should contain sufficient antibody for a single experiment or application.

When handling the antibody, allow it to equilibrate to room temperature slowly before opening the vial to prevent condensation that could introduce contaminants or affect antibody concentration. For short-term storage during experiments, keeping the antibody on ice (4°C) is appropriate, but return to -20°C or -80°C for long-term storage.

What controls should be included when using aex-2 antibodies in experiments?

When designing experiments with aex-2 antibodies, the following controls should be included:

  • Positive control: Use the provided 200μg of antigen to verify antibody binding specificity and establish signal baseline

  • Negative control: Use the provided pre-immune serum to assess background signal and non-specific binding

  • No-primary control: Omit the primary antibody to evaluate secondary antibody non-specific binding

  • Competitive inhibition: Pre-incubate the antibody with excess target antigen to demonstrate binding specificity

  • Genetic control: If available, use aex-2 knockout or knockdown C. elegans samples to confirm signal specificity

How should aex-2 antibody be optimized for Western blot applications in C. elegans research?

For optimal Western blot results with aex-2 antibody:

  • Sample preparation:

    • Extract proteins from synchronized C. elegans populations to ensure developmental stage consistency

    • Use appropriate lysis buffers containing protease inhibitors to prevent protein degradation

    • Denature samples at 95°C for 5 minutes in loading buffer containing SDS and β-mercaptoethanol

  • Gel electrophoresis and transfer:

    • Use 10-12% polyacrylamide gels for optimal resolution of aex-2 protein

    • Transfer to PVDF membranes at 100V for 1 hour in cold transfer buffer containing 20% methanol

  • Antibody incubation:

    • Block membranes with 5% non-fat dry milk in TBST for 1 hour at room temperature

    • Dilute aex-2 antibody (start with 1:1000 and optimize as needed)

    • Incubate overnight at 4°C with gentle rocking

    • Wash extensively with TBST (4 × 5 minutes)

    • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour at room temperature

    • Develop using enhanced chemiluminescence

  • Data analysis:

    • Compare band intensities across experimental conditions using densitometry

    • Normalize to loading controls such as actin or tubulin

How can aex-2 antibodies be effectively used in immunohistochemistry for neural circuit mapping?

For neural circuit mapping using aex-2 antibodies in C. elegans:

  • Specimen preparation:

    • Fix worms in 4% paraformaldehyde for 12-24 hours at 4°C

    • Permeabilize cuticle using freeze-crack method or by cutting heads/tails

    • Block with 1% BSA and 0.1% Triton X-100 in PBS for 1 hour

  • Antibody staining:

    • Dilute aex-2 antibody 1:200-1:500 in blocking buffer

    • Co-stain with neuronal markers (e.g., anti-GFP for transgenic lines expressing GFP in specific neurons)

    • Include DAPI for nuclear counterstaining

    • Incubate primary antibodies for 24-48 hours at 4°C

    • Wash extensively (4 × 30 minutes) with PBS containing 0.1% Tween-20

    • Apply fluorescent secondary antibodies and incubate overnight at 4°C

  • Imaging and analysis:

    • Use confocal microscopy with appropriate filter sets

    • Obtain z-stacks at 0.5-1μm intervals

    • Perform 3D reconstruction to map neural connections

    • Quantify colocalization with other neural markers using appropriate software

What strategies can address cross-reactivity concerns when using aex-2 antibodies?

To address potential cross-reactivity issues with aex-2 antibodies:

  • Epitope analysis:

    • Determine the specific epitope(s) recognized by the antibody

    • Compare sequence homology with related proteins in C. elegans

    • Identify potential cross-reactive proteins using bioinformatics tools

  • Experimental validation:

    • Perform competitive binding assays with recombinant aex-2 protein

    • Test antibody reactivity in aex-2 knockout/knockdown samples

    • Use peptide competition assays with specific epitope peptides

  • Signal verification:

    • Compare antibody staining patterns with mRNA expression data

    • Validate with orthogonal methods (e.g., fluorescent protein tagging of aex-2)

    • Use super-resolution microscopy for detailed localization studies

  • Antibody purification:

    • Consider affinity purification against specific epitopes

    • Use cross-adsorption against related proteins to remove cross-reactive antibodies

    • Validate purified antibody fractions with dot blots against potential cross-reactive proteins

How can aex-2 antibody be used to investigate changes in aex-2 expression during experimental evolution studies?

For studying aex-2 expression changes during experimental evolution:

  • Experimental design:

    • Establish multiple replicate populations of C. elegans under selection conditions

    • Maintain control populations under standard conditions

    • Sample populations at regular intervals during evolution (e.g., every 5-10 generations)

    • Preserve samples for both protein and RNA analysis

  • Protein expression analysis:

    • Extract proteins from whole worms or specific tissues

    • Perform quantitative Western blot analysis with aex-2 antibody

    • Use standardized loading and analysis protocols across all timepoints

    • Create a temporal profile of aex-2 expression changes

  • Correlation with phenotypic changes:

    • Track behavioral phenotypes related to aex-2 function (e.g., defecation cycle)

    • Correlate protein expression changes with phenotypic adaptations

    • Analyze genetic changes in the aex-2 locus in evolved populations

  • Comparative analysis:

    • Create a data table comparing aex-2 expression levels across:

      • Different environmental conditions

      • Timepoints during experimental evolution

      • Replicate populations

    • Perform statistical analysis to identify significant trends and correlations

What methodological considerations are important when using aex-2 antibodies in combination with other experimental techniques?

When integrating aex-2 antibody-based techniques with other experimental approaches:

  • Sequential immunoprecipitation and mass spectrometry:

    • Use aex-2 antibody for immunoprecipitation of protein complexes

    • Perform stringent washing to remove non-specific interactions

    • Analyze precipitated proteins by mass spectrometry to identify interaction partners

    • Validate interactions with reciprocal co-immunoprecipitation experiments

  • Combined immunostaining and CRISPR/Cas9 genome editing:

    • Generate CRISPR/Cas9 edits in the aex-2 gene

    • Use aex-2 antibody to confirm knockout or protein modification

    • Compare antibody staining patterns between wild-type and edited strains

    • Correlate staining patterns with phenotypic changes

  • Integration with transcriptomics:

    • Compare protein expression patterns detected by aex-2 antibody with RNA-seq data

    • Investigate post-transcriptional regulation by comparing mRNA and protein levels

    • Identify discrepancies that might indicate regulatory mechanisms

  • Considerations for C. elegans developmental studies:

    • Synchronize worm populations using standard techniques

    • Sample at specific developmental timepoints

    • Use appropriate fixation methods that preserve epitope accessibility

    • Consider developmental changes in aex-2 expression when interpreting results

What are common issues encountered when using aex-2 antibodies and how can they be resolved?

ProblemPossible CausesSolutions
No signal in Western blotInsufficient protein loading, degraded antibody, improper transferIncrease protein concentration, verify antibody activity with positive control, optimize transfer conditions
High backgroundInsufficient blocking, antibody concentration too high, inadequate washingExtend blocking time, titrate antibody concentration, increase wash duration and frequency
Non-specific bandsCross-reactivity, protein degradation, secondary antibody issuesPerform peptide competition, add protease inhibitors, optimize secondary antibody dilution
Variable results between replicatesInconsistent sample preparation, variable transfer efficiencyStandardize lysis procedure, use internal loading controls, employ consistent transfer methods
Weak signalLow protein expression, inefficient extraction, suboptimal antibody concentrationEnrich for target tissue, optimize extraction buffer, increase antibody concentration or incubation time

How can researchers validate aex-2 antibody specificity in transgenic C. elegans models?

To validate antibody specificity in transgenic models:

  • Genetic validation approaches:

    • Generate aex-2 knockout strains using CRISPR/Cas9

    • Create aex-2 overexpression lines with epitope tags

    • Develop tissue-specific knockdown lines using RNAi

  • Experimental validation:

    • Compare antibody staining between wild-type and knockout strains

    • Colocalize antibody signal with fluorescent tags in transgenic lines

    • Perform quantitative analysis of signal intensity across different genetic backgrounds

  • Quantitative assessment:

    • Measure signal-to-noise ratios in different genetic backgrounds

    • Calculate Pearson's correlation coefficient for colocalization studies

    • Perform Western blot analysis with densitometry across genetic variants

  • Documentation and reporting:

    • Record detailed validation protocols and results

    • Include representative images showing specificity

    • Report quantitative measures of antibody performance

How can aex-2 antibodies contribute to understanding host-pathogen interactions in C. elegans?

The aex-2 antibody can be valuable for investigating host-pathogen interactions:

  • Infection response studies:

    • Monitor changes in aex-2 expression during pathogen exposure

    • Investigate potential pathogen-induced modifications of aex-2 protein

    • Examine aex-2's role in neural circuits that regulate pathogen avoidance behaviors

  • Methodology for infection experiments:

    • Expose synchronized worm populations to pathogens (e.g., Pseudomonas aeruginosa)

    • Collect samples at defined timepoints post-infection

    • Process for both immunostaining and protein extraction

    • Compare aex-2 expression and localization between infected and control worms

  • Integration with immunity pathways:

    • Investigate potential interactions between aex-2 and innate immune signaling

    • Use genetic epistasis experiments combined with antibody detection to place aex-2 in immunity pathways

    • Examine co-localization with known immune regulators during infection

What considerations are important when adapting aex-2 antibody protocols for use in other Caenorhabditis species?

When extending aex-2 antibody usage to other nematode species:

  • Sequence homology analysis:

    • Compare aex-2 protein sequences across species (e.g., C. elegans, C. briggsae, C. remanei)

    • Identify conserved and divergent epitopes

    • Predict potential cross-reactivity based on sequence conservation

  • Protocol modifications:

    • Adjust fixation conditions for species-specific cuticle differences

    • Optimize antibody concentration for each species

    • Modify incubation times based on tissue accessibility

    • Develop species-specific controls for validation

  • Cross-species validation:

    • Test antibody reactivity in Western blots across species

    • Compare immunostaining patterns with predicted expression based on conserved neural circuits

    • Validate with genetic approaches when possible in each species

How might aex-2 antibodies be used in studying the evolution of neural circuits across Caenorhabditis species?

For evolutionary neurobiology research:

  • Comparative neuroanatomy approach:

    • Use aex-2 antibody to map neural expression across multiple Caenorhabditis species

    • Compare expression patterns in homologous neurons and circuits

    • Correlate differences with behavioral or functional divergence

  • Experimental methodology:

    • Process multiple species in parallel using standardized protocols

    • Use identical antibody concentrations and imaging settings

    • Perform quantitative analysis of expression intensity and pattern

    • Create detailed anatomical maps for cross-species comparison

  • Integration with evolutionary studies:

    • Link neural circuit differences to adaptive changes in behavior

    • Correlate molecular evolution of aex-2 with expression pattern changes

    • Investigate how selection pressures shape neural circuit architecture

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.